Argos Therapeutics - Company & Market Research Reports

Argos Therapeutics develops individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. In addition, its development stage products include AGS-003, for the treatment of metastatic renal cell carcinoma; and AGS-004, for the treatment of human immunodeficiency virus. Argos Therapeutics was founded in 1997 and is headquartered in Durham, North Carolina.

From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Cancer Cell Therapy Market & Pipeline Insight - Product Thumbnail Image

Cancer Cell Therapy Market & Pipeline Insight

  • Drug Pipelines
  • 195 Pages
From
From
From
Loading Indicator
adroll